-6.5 C
Ottawa
Friday, December 12, 2025

Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

Date:

Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

The Genentech logo displayed at the company’s headquarters in San Francisco in a file photo. Justin Sullivan/Getty Images

Roche Group’s Genentech has joined the growing ranks of pharmaceutical companies selling prescription drugs directly to patients by making its Xofluza antiviral flu medicine available through online pharmacies.

Genentech’s Direct-to-Patient (DTP) program allows patients to order the single-dose vaccine from Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus Drugs, San Francisco-based Genentech said on Oct. 16. Patients can order the vaccine for $50, a 70-percent reduction from its list price, Genentech said.

About the author: Rob Sabo
Tell us something about yourself.
spot_imgspot_imgspot_img

Share post:

More like this
Related

DHS Ends Temporary Protected Status for Ethiopians

Homeland Security Secretary Kristi Noem speaks at the Citadel...

Watchdog Finds 9 Large US Banks Actively Engaged in Debanking

People pass by a sign for JPMorgan Chase at...

Dont Settle for a Subpar Health Savings Account

Paired with high-deductible healthcare plans (HDHPs), health savings accounts...

Trump Admin Confirms Backup Plan If Supreme Court Rules Against Tariffs

Jamieson Greer, the U.S. Trade Representative, speaks to reporters...